Aug 10, 2026 11:46AM RBC Capital Upgrades Sionna Therapeutics (SION) to Sector Perform

Aug 10, 2026 11:45AM Citizens Downgrades Sionna Therapeutics (SION) to Market Perform

Aug 10, 2026 11:44AM Raymond James Downgrades Sionna Therapeutics (SION) to Market Perform

Aug 10, 2026 10:42AM Wedbush Downgrades Sionna Therapeutics (SION) to Neutral

Aug 10, 2026 10:01AM Vertex stock jumps as rival cystic fibrosis drug fails trial

Aug 10, 2026 09:22AM Stifel Downgrades Sionna Therapeutics (SION) to Hold

Aug 10, 2026 07:00AM Sionna CF drug trial fails key endpoint; company halts program

Aug 6, 2026 10:24AM Sionna Therapeutics (SION) PT Raised to $59 at Raymond James

Aug 6, 2026 08:51AM Sionna Therapeutics (SION) Misses Q2 EPS by 14c

Jun 23, 2026 04:36AM Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming

May 26, 2026 07:52AM Sionna Therapeutics (SION) Reiterated at Buy by Stifel After CEO Meet

May 26, 2026 04:42AM Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens

May 20, 2026 10:44AM Freedom Broker Downgrades Sionna Therapeutics (SION) to Hold

May 18, 2026 07:56AM Sionna Therapeutics (SION) PT Raised to $55 at Stifel On Optimism about ph2a data

May 12, 2026 04:33PM Sionna Therapeutics (SION) Misses Q1 EPS by 60c

May 12, 2026 12:20PM Guggenheim on Sionna Therapeutics (SION): 'We think these readouts are highly meaningful catalysts for the company'

May 12, 2026 09:47AM Raymond James Defending Sionna Therapeutics (SION) Amid 7% Selloff

May 12, 2026 09:17AM Wedbush on Sionna Therapeutics (SION): 'We continue to hold a positive bias'

May 4, 2026 04:06PM Wedbush Starts Sionna Therapeutics (SION) at Outperform

Apr 28, 2026 06:04AM Sionna Therapeutics (SION) PT Raised to $63 at Jones Trading

Mar 2, 2026 04:12PM SION (SION) Tops Q4 EPS by 25c

Mar 2, 2026 11:46AM Sionna Therapeutics (SION) PT Raised to $50 at Guggenheim following FY25 earnings report

Mar 2, 2026 08:21AM Sionna Therapeutics (SION) files mixed shelf

Feb 24, 2026 03:13AM Citizens Starts Sionna Therapeutics (SION) at Market Outperform

Jan 5, 2026 06:24AM Sionna Therapeutics (SION) PT Raised to $53 at Raymond James

Dec 1, 2025 05:09AM RBC Capital Downgrades Sionna Therapeutics (SION) to Underperform

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 5, 2025 10:50AM Raymond James Positive on Sionna Therapeutics (SION): 'continue to like the set-up into initial POC data next year'

Oct 17, 2025 10:16AM Freedom Capital Markets Starts Sionna Therapeutics (SION) at Buy

Sep 8, 2025 08:02AM Sionna Therapeutics names Caroline Stark Beer as chief business officer

Sep 8, 2025 07:02AM Jones Trading Starts Sionna Therapeutics (SION) at Buy, PT $46

Sep 3, 2025 05:11AM RBC Capital Starts Sionna Therapeutics (SION) at Sector Perform

Aug 12, 2025 01:41AM Sionna Therapeutics (SION) Misses Q2 EPS by 41c

Aug 11, 2025 12:05PM Guggenheim on Sionna Therapeutics (SION): 'we continue to believe SION has the potential to revolutionize the cystic fibrosis treatment paradigm with its first-in-class NBD1 stabilizers'

Jun 6, 2025 11:00AM Sionna Therapeutics (SION) Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model

Jun 4, 2025 09:05AM Stifel on Sionna Therapeutics (SION): 'both compounds are able to attain exposures well above the modeled PK threshold'

Jun 4, 2025 07:00AM Sionna Therapeutics (SION) Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451

May 13, 2025 06:29AM Sionna Therapeutics, Inc. (SION) Reports Q1 Loss of $0.62

Mar 20, 2025 04:15PM (SION) Misses Q4 EPS by 338c

Mar 20, 2025 11:47AM Stifel on Sionna Therapeutics (SION): 'we like the stock set up here'

Mar 4, 2025 06:14AM TD Cowen Starts Sionna Therapeutics (SION) at Buy

Mar 4, 2025 01:08AM Stifel Starts Sionna Therapeutics (SION) at Buy

Mar 4, 2025 01:07AM Guggenheim Starts Sionna Therapeutics (SION) at Buy